Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Autologous Dendritic Cells Pulsed by Melanoma Associated Peptides to Augment the Therapeutic Effect of Interleukin-2

NCT00279058 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00279058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00279058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Autologous Dendritic Cells Pulsed by Melanoma Associated Peptides to Augment the Therapeutic Effect of Interleukin-2
Lead sponsor
Hadassah Medical Organization
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2005
Completion date
December 31, 2008
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma